CAMPUSES:    CHICAGO    |   PEORIA   | ROCKFORD   |   URBANA

ABOUT       ADMISSIONS      DEPARTMENTS & PROGRAMS       RESEARCH      STUDENT SERVICES      GIVING      MEDICAL CENTER

INFO FOR:

Medicine

GO

Copyright @2014     University of Illinois College of Medicine all rights reserved | LOGIN / LOGOUT

If you have questions, comments, or problems accessing this site, please E-mail the webmaster

Privacy Statement | Public Formal Grievance Procedures | Strategic Planning Document | Health Care Industry Conflict of Interest Guidelines


About | Admissions |Departments & Programs |Research |Student Services |Patient Services |News |Alumni and Friends

University of Illinois College of Medicine at Chicago >> Education, Departments & Programs >> Departments >> Research >> Dean E Schraufnagel MD

Dean E. Schraufnagel, M.D.


Academic Title: Professor of Medicine and Pathology                                                                                    

Administrative Positions: Vice Chair for Faculty Affairs; Department of Medicine; Director, Pulmonary and Critical Care Fellowship

Division: Pulmonary, Critical Care, Sleep and Allergy Medicine

Location: 840 S. Wood St., Bldg 920N (MC 719), Chicago, IL 60612-7323

Phone: (312)996-8039 (Office) Fax: (312)996-4665

E-mail: schrauf@uic.edu


Education:

MD, University of Wisconsin, Madison WI (1974)

Resident, University of Illinois at Chicago, Chicago, IL (1974-1977)

Fellow, McGill University, Montreal, CA (1977-1981)


Faculty Positions:


Clinical Specialties


Research Interests


Selected Publications

Books

  1. Schraufnagel DE (ed): Electron Microscopy of the lung. Marcel Dekker, New York, NY, 1990.
  2. Schraufnagel DE (ed): “I Remember…” Reflections on the American Thorasic Society’s First Century. American Thoracic Society, New York, NY, 2005.
  3. Mason RJ, Kimg TE, Martin TR, Boaddus VC, Schraufnagel DE, Nadel JA, Murray JF (eds): Murray and Nadel, Textbook of Respiratory Medicine. Fifth ed. Elsevier, New York, NY, 2010.
  4. Schraufnagel DE (ed): Breathing in America: Diseases, Progress, and Hope. American Thoracic Society, New York, NY, 2010.


Original Research Articles

  1. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N and Metersky M; Scleroderma Lung Study Research Group. Cyclophosphamide versus placebo in scleroderma lung disease. N. Engl. J. Med. 354(25):2655-66, 2006.
  2. Clements PJ, Roth MD, Elashoff R, Tashkin DP, Goldin J, Silver RM, Sterz M, Seibold JR, Schraufnagel D, Simms RW, Bolster M, Wise RA, Steen V, Mayes MD, Connelly K, Metersky M, Furst DE; Scleroderma Lung Study Group. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis. 66:1641-7, 2007.
  3. Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, Goldin J, Arriola E, Strange C, Bolster MB, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel D, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Khanna D, Li N and Li G; Scleroderma Lung Study Research Group. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am. J. Respir. Crit. Care Med. 15;176(10):1026-34, 2007.
  4. Maniatis NA, Shinin V, Schraufnagel DE, Okada S, Vogel SM, Malik AB and Minshall RD. Increased pulmonary vascular resistance and defective pulmonary artery filling in caveolin-1-/- mice. Am. J. Physiol. Lung Cell Mol. Physiol. 294(5):L865-73, 2008.
  5. Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, Elashoff RM, Furst DE, Vasunilashorn S, McNitt-Gray MF, Brown MS, Roth MD and Tashkin DP; Scleroderma Lung Study Research Group. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest. 134(2):358-67, 2008.
  6. Schraufnagel DE, Michel JC, Sheppard TJ, Saffold PC, Kondos GT. The normal esophagus: a CT study to define the normal air column, its extent and distribution. AJR Am J Roentgenol. 191:748-52, 2008.
  7. Schraufnagel, DE. Lung lymphatic anatomy and correlates. Pathophysiology. 17:337-43, 2010.
  8. Furst DE, Tseng CH, Clements PJ, Strange C, Tashkin DP, Roth MD, Khanna D, Li N, Elashoff R and Schraufnagel DE; Scleroderma Lung Study. Adverse Events during the Scleroderma Lung Study. Am. J. Med. 124:459-67, 2011.
  9. Machado RF, Barst RJ, Yovetich NA, Hassell KL, Kato GJ, Gordeuk VR, Gibbs JS, Little JA, Schraufnagel DE, Krishnamurti L, Girgis RE, Morris CR, Rosenzweig EB, Badesch D, Lanzkron S, Onyekwere O, Castro OL, Sachdev V, Waclawiw MA, Woolson R, Goldsmith JC and Gladwin MT. Hospitalization for Pain in Patients with Sickle Cell Disease Treated with Sildenafil for Elevated TRV and Low Exercise Capacity. Blood. 28:855-64, 2011.
  10. Sachdev V, Kato GJ, Gibbs JS, Barst RJ, Machado RF, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli EM, Girgis RE, Morris CR, Rosenzweig EB, Badesch DB, Lanzkron S, Castro OL, Taylor JG 6th, Hannoush H, Goldsmith JC, Gladwin MT, Gordeuk VR; Walk-PHASST Investigators. Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom. Circulation. 124:1452-60, 2011.
  11. Tauseef M, Knezevic N, Chava KR, Smith M, Sukriti S, Gianaris N, Obukhov AG,Vogel SM, Schraufnagel DE, Dietrich A, Birnbaumer L, Malik AB and Mehta D. TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation. J. Exp. Med. 209(11):1953-68, 2012.
  12. Nouraie M, Lee JS, Zhang Y, Kanias T, Zhao X, Xiong Z, Oriss TB, Zeng Q, Kato GJ, Gibbs JS, Hildesheim ME, Sachdev V, Barst RJ, Machado RF, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Rosenzweig EB, Badesch DB, Lanzkron S, Castro OL, Goldsmith JC, Gordeuk VR and Gladwin MT; Walk-PHASST Investigators and Patients. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica. 98(3):464-72, 2013.